Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Korea Pharma Company Ltd
WARNING LETTER
•Korea Pharma Company Ltd

Korea Pharma Company Ltd – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to Korea Pharma Company Ltd on March 26, 2012, for failing to fulfill drug establishment registration obligations. The company continued to manufacture and import drugs into the U.S. in 2011 and 2012 without registering its establishment, despite an August 8, 2011, notification from the FDA.

This failure violates Section 510(i)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 360(i)(1)), which requires annual electronic registration for foreign establishments manufacturing drugs imported into the U.S. It is also a prohibited act under Section 301(p) (21 U.S.C. § 331(p)). Additionally, drugs cannot be imported unless listed per 21 CFR Part 207, Subpart C, and manufactured at a registered foreign establishment (21 CFR § 207.40(b)).

Unregistered drugs may be refused admission under Section 801(o) (21 U.S.C. § 381(o)) and Section 801(a)(3) (21 U.S.C. § 381(a)(3)) if appearing adulterated or misbranded. Failure to list drugs as required by Section 51

Company
Korea Pharma Company Ltd
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Douglas Stearn
View Company Profile

ID · d878aeb0-fd71-4d4b-94b1-d4211229398a

Violation Codes10
21 U.S.C. 360(i)(1)21 U.S.C. 331(p)21 CFR 207.40(b)21 U.S.C. 381(o)21 U.S.C. 360(i)21 U.S.C. 381(a)(3)21 U.S.C. 352(o)21 CFR 20721 CFR 207.30(a)21 CFR 207.25(b)(7)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Korea Pharma Company Ltd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.